000 | 01025 a2200265 4500 | ||
---|---|---|---|
005 | 20250512035250.0 | ||
264 | 0 | _c19880527 | |
008 | 198805s 0 0 eng d | ||
022 | _a0340-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKruithof, E K | |
245 | 0 | 0 |
_aPlasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cFeb 1988 |
||
300 |
_a7-12 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aGlycoproteins _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlasminogen Activators _xantagonists & inhibitors |
650 | 0 | 4 | _aPlasminogen Inactivators |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xantagonists & inhibitors |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
700 | 1 | _aGudinchet, A | |
700 | 1 | _aBachmann, F | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 59 _gno. 1 _gp. 7-12 |
|
999 |
_c3135607 _d3135607 |